| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |